In 2023, hospital discharges for malignant neoplasm of the prostate in Canada stood at a specific level. From 2024, forecasted data indicates a consistent annual decrease in discharges per hundred thousand persons, with a year-on-year decline of about 1.52% by 2028. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 reflects an average annual decline of approximately 1.17%.
Future trends to watch for include:
- Advancements in early detection and treatment technologies.
- Potential shifts in health policies targeting preventive measures.
- Impact of demographic changes and healthcare accessibility on discharge rates.
